R-2HG Targets FTO to Increase m6A Levels and Suppress Tumor Growth [Research Watch]

R-2HG, thought to be an oncometabolite in IDH-mutant tumors, has antitumor activity in leukemia and glioma.

from Cancer via ola Kala on Inoreader http://ift.tt/2BiWkAK
via IFTTT